These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 8381316)
21. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase. Gil DW; Wolfe BB J Pharmacol Exp Ther; 1985 Mar; 232(3):608-16. PubMed ID: 2579230 [TBL] [Abstract][Full Text] [Related]
22. Differences in muscarinic receptor reserve for inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis in chick heart cells. Brown JH; Goldstein D Mol Pharmacol; 1986 Dec; 30(6):566-70. PubMed ID: 3023810 [TBL] [Abstract][Full Text] [Related]
23. Muscarinic cholinergic ligand binding to intact mouse pituitary tumor cells (AtT-20/D16-16) coupling with two biochemical effectors: adenylate cyclase and phosphatidylinositol turnover. Akiyama K; Vickroy TW; Watson M; Roeske WR; Reisine TD; Smith TL; Yamamura HI J Pharmacol Exp Ther; 1986 Mar; 236(3):653-61. PubMed ID: 3005550 [TBL] [Abstract][Full Text] [Related]
24. Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes. Peralta EG; Ashkenazi A; Winslow JW; Ramachandran J; Capon DJ Nature; 1988 Aug; 334(6181):434-7. PubMed ID: 2841607 [TBL] [Abstract][Full Text] [Related]
25. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex. Forray C; el-Fakahany EE Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015 [TBL] [Abstract][Full Text] [Related]
26. Developmental changes in muscarinic receptor-stimulated phosphoinositide metabolism in rat brain. Balduini W; Murphy SD; Costa LG J Pharmacol Exp Ther; 1987 May; 241(2):421-7. PubMed ID: 3033215 [TBL] [Abstract][Full Text] [Related]
27. Presence of m3 subtype muscarinic acetylcholine receptors and receptor-mediated increases in the cytoplasmic concentration of Ca2+ in Jurkat, a human leukemic helper T lymphocyte line. Kaneda T; Kitamura Y; Nomura Y Mol Pharmacol; 1993 Mar; 43(3):356-64. PubMed ID: 8383801 [TBL] [Abstract][Full Text] [Related]
28. Cyclic adenosine 3',5'-monophosphate in human lymphocytes. Alterations after phytohemagglutinin stimulation. Smith JW; Steiner AL; Newberry WM; Parker CW J Clin Invest; 1971 Feb; 50(2):432-41. PubMed ID: 4395563 [TBL] [Abstract][Full Text] [Related]
29. Muscarinic regulation of cyclic AMP in bovine trachealis cells. Schaefer OP; Ethier MF; Madison JM Am J Respir Cell Mol Biol; 1995 Aug; 13(2):217-26. PubMed ID: 7626289 [TBL] [Abstract][Full Text] [Related]
30. Characterization of adenylate cyclase activity in asthmatic neutrophil sonicates. Galant SP; Allred S; Griffiths R Am Rev Respir Dis; 1980 Aug; 122(2):231-8. PubMed ID: 6251741 [No Abstract] [Full Text] [Related]
31. Coupling of subtypes of the muscarinic receptor to adenylate cyclase in the corpus striatum and heart. Ehlert FJ; Delen FM; Yun SH; Friedman DJ; Self DW J Pharmacol Exp Ther; 1989 Nov; 251(2):660-71. PubMed ID: 2810116 [TBL] [Abstract][Full Text] [Related]
32. A role for muscarinic excitation: control of specific singing behavior by activation of the adenylate cyclase pathway in the brain of grasshoppers. Heinrich R; Wenzel B; Elsner N Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9919-23. PubMed ID: 11438697 [TBL] [Abstract][Full Text] [Related]
33. Galphaq potentiation of adenylate cyclase type 9 activity through a Ca2+/calmodulin-dependent pathway. Cumbay MG; Watts VJ Biochem Pharmacol; 2005 Apr; 69(8):1247-56. PubMed ID: 15794946 [TBL] [Abstract][Full Text] [Related]